Purpose of review The kidney mediates the excretion or conservation of water and electrolytes in the face of changing fluid and salt intake and losses. To ultrafilter and reabsorb the exact quantities of free water and salts to maintain euvolemia a range of endocrine, paracrine, and hormonal signaling systems have evolved linking the tubules, capillaries, glomeruli, arterioles, and other intrinsic cells of the kidney. Our understanding of these systems remains incomplete.
INTRODUCTION
The kidneys mediate waste excretion, water, and electrolyte balance. They also maintain systemic blood pressure (BP), bone calcification, and stimulate red blood cell production. In addition to responding to systemic hormonal cues, autocrine and paracrine signaling pathways exist within the kidney itself [1 & ]. These signaling pathways may be adaptive during normal physiological function or maladaptive in disease. They facilitate communication among podocytes, vascular endothelium, stroma, and epithelial cells at different levels of the nephron to respond to physiologic and pathophysiological changes [2] . This article reviews our current understanding of signaling mechanisms among tubular, interstitial, vascular, and glomerular cells, with an emphasis on recent progress in this field. The relevance of these systems in health, disease and therapy will be discussed.
ATP
ATP is the essential energy source fueling the metabolic reactions within all cells [3] . Although generated within mitochondria and predominantly intracellular, it is now recognized as a paracrine signal that acts among renal tubules [4, 5] . The stimuli and mechanisms responsible for tubular extracellular ATP (eATP) secretion remain incompletely understood. Evidence in vitro suggests exit from the cell via membrane channels [6] and release via vesicular fusion with the membrane [7] .
At one-thousandth of the intracellular concentration, eATP facilitates autocrine and paracrine signaling among renal tubular cells. It ligates two families of purinergic receptors -ionotropic (P2X), and metabolotropic (P2Y) [8 are the focus of ongoing research. There is evidence for the expression at the mRNA level and activation of all P2XR and some P2YRs within the kidney [9] .
Tubular cells release eATP in response to cell swelling or increased renal tubular flow. This allows flow rates in one nephron segment to influence NaCl adsorption, extracellular fluid volume status, electrolyte balance, and BP by paracrine mechanisms [1 & ]. eATP also impacts renal hemodynamics causing renal vasodilation via P2XR and P2YR activation [10] .
Pathological functions of extracellular ATP
Activation of the P2X7 receptor results in microvascular dysfunction and regional hypoxia when angiotensin II (ATII) is infused into rats, and these effects may contribute to progression of renal injury induced by chronic ATII elevation [11 & ]. In the mouse, P2X7 receptor inhibition protects against ischemia reperfusion injury (IRI), with protection also seen in the unilateral ureteric obstruction (UUO) model in rats [ [14] .
In the extracellular environment, ATP and adenosine diphosphate (ADP) are converted to adenosine with ecto-5'-nucleotidase CD73 a major enzyme responsible. Rats lacking CD73 or adenosine A 2B R (upregulated in diabetic nephropathy) develop worsened diabetic nephropathy [15 && ]. Few studies explore the associations between gene polymorphisms of ATP receptors and human disease. One study reported P2X 7 R polymorphism influencing BP [16], but has not been replicated [17] .
ENDOTHELIN-1
Endothelin-1 (ET-1) is a vasoconstrictor which regulates salt and water clearance, and influences systemic BP. ET-1 is expressed within the tubular cells of the inner medullary collecting duct and secreted across the basolateral membrane. ET-1 production and secretion is stimulated by volume loading, augmented by inflammatory cytokines in vivo, and is elevated in most cases of clinical chronic kidney disease (CKD) [18] . ET-1 synthesis in the canine kidney is inhibited by both prostacyclins and nitric oxide [19] .
There are two groups of recognized endothelin receptors within the kidney, ET A and ET B [20 & ]. Both are expressed in the inner medullary collecting duct, allowing autocrine and paracrine signaling to take place in these cells. ET-1 and its receptors provide negative feedback control in response to increased arginine vasopressin (AVP)-induced osmotic water permeability. Thick ascending limbs (TALs) and collecting ducts both express ET B receptors, and stimulation by ET-1 causes inhibition of NaCl transport and stimulation of nitric oxide synthase (NOS). The increased production of nitric oxide inhibits Na þ K þ -ATPase and epithelial sodium channel (ENaC) within the distal convoluted tubules and the collecting ducts [21] .
Pathological role for endothelin-1 in renal disease
Increased ET-1 levels are believed to be pathogenic in diabetic and nondiabetic CKD, contributing to renal hypoxia, inflammation, and fibrosis [18, 21] . These effects are predominantly because ligation of the renal ET A receptor promotes vasoconstriction, cell proliferation, and matrix accumulation [18] . Clinical trials of endothelin receptor antagonists demonstrate antiproteinuric effects beyond those expected from their antihypertensive actions (reviewed in [18, 22] ). Analyses have shown that lowered estimated glomerular filtration rate (eGFR) and diabetes predispose patients to fluid retention, complicating the use of endothelin receptor antagonists in renal patients [23 & ].
(PCT), TAL, and collecting duct; NOS2 within PCT, TAL, distal convoluted tubules, and collecting duct cells; whereas NOS1 is found at low levels in the TAL and collecting duct (Fig. 1) . Tubular epithelial nitric oxide exerts autocrine and paracrine effects promoting natriuresis and diuresis, and conveys signals to the adjacent vasculature [25] . Physiologic renal nitric oxide release has beneficial effects on renal hemodynamics and function, whereas experimental models with reduced nitric oxide demonstrate increased effects of ATII [26] .
Role of nitric oxide in renal pathology
Renal nitric oxide levels decline with advancing stages of CKD [27] . Insulin simulates NOS3 within the kidney, and insulin deficiency may influence both BP and renal perfusion via effects on nitric oxide [28 & ]. Aristolochic acid nephropathy (AAN) induces tubular injury and transient reductions in renal nitric oxide generation. Murine AAN studies show that arginine supplementation increases nitric oxide availability, reduces free radical generation, and reduces renal injury [29] . Studies of experimental IRI demonstrate that preinduction of nitric oxide ameliorates disease severity, while cotreatment with nitric oxide-inhibitors abolishes protection [30] . Potentiating tubular nitric oxide production merits investigation as a translational protective therapy for acute and chronic renal injury [31] .
DOPAMINE
Renal dopamine is generated within the cells of the PCT, and secreted through the apical and basolateral membranes exhibiting local paracrine effects and hormonal actions, via the blood stream, on distal nephron segments [32] .
Dopamine signals via five known receptors, broadly grouped into D 1 -like (D 1 and D 5 receptors) and D 2 -like (D 2 , D 3 , and D 4 ) groups. In the kidney, the D 1 receptor family is expressed throughout the nephron, juxtaglomerular apparatus, and vasculature [33] (Fig. 2) . D 1 -like receptors inhibit salt and water transport in tubular cells, relax vascular smooth muscle, and inhibit sympathetic nervous system activity [34, 35] . Stimulation of D 1 -like receptors is associated with natriuresis and diuresis in states of sodium loading, without a requirement for increased renal blood flow [36, 37] . During sodium depletion, the effects of D 1 -like receptor ligation are largely lost, with recent work implicating an interaction with the renin-angiotensin signaling pathway [38 && ]. Renal D 2 receptors also impact salt and water uptake and vascular tone. Studies examining polymorphisms within the human D 2 receptor gene have shown a correlation with hypertension in clinical cohorts [35] 
Role of dopamine and dopamine receptors in hypertension
Selective dopamine deficiency in the murine kidney is associated with progressive fibrosis [45] , and in man dopamine deficiency is linked with salt-sensitive hypertension [46 & ]. The current knowledge of essential hypertension implicates a desensitization of the kidney to endogenous dopamine production via changes in expression of dopamine signaling via the G protein-coupled receptor kinase 4 [47] . Clinical cohort studies have identified G protein-coupled receptor kinase 4 polymorphisms as contributing to hypertension and treatment responses [48, 49] . Mice with D 2 -receptor family defects have renindependent hypertension ameliorated by upregulation of D 5 receptors [50] . In wild type mice, treatment with a D 3 -receptor antagonist induces hypertension when combined with chronically elevated sodium intake [51] . Dopamine produced by the tubules acts throughout the nephron to enhance sodium excretion via its receptors. Defects of production or receptor function leads to abnormal sodium handling and salt-sensitive hypertension [46 & ].
ANGIOTENSIN II
ATII is also synthesized and released from the proximal tubule, and impacts renal water and electrolyte uptake. ATII stimulates sodium uptake by the cells of the PCT, TAL, and the collecting duct [52 & ]. ATII augments salt and water uptake via the tubular AT 1 receptor with this receptor implicated as a driver of systemic hypertension [53] . Via hormonal or paracrine signaling, ATII also induces proliferation, hypertrophy, inflammation, and matrix production by tubular cells [54] . Additionally, ATII mediates tubule-tubule crosstalk indirectly via interstitial pericytes and fibrocytes [55] .
Angiotensin II in renal disease
ATII is the main effector of the renin-angiotensin system in the kidney, promoting fibrosis and tubular cell loss. Excess ATII production is a common feature of CKD, including that resulting from diabetic nephropathy [54] . ATII uptake within the tubular cells themselves stimulates production of transforming growth factor (TGF)-b1, interstitial inflammation, pericyte detachment of the endothelium, activation and transdifferentiation to myofibroblasts, vascular rarefaction, vasoconstriction, secondary ischemia, and tubular cell loss [56] . Treatment with angiotensin converting enzyme (ACE) 
BRADYKININ
Bradykinin is a vasodilatory nine-amino acid peptide with effects on the heart, kidney, and systemic blood vessels [60] . Within the kidney bradykinin is synthesized by the TAL and collecting duct and secreted across apical and basolateral membranes [61 & ]. Many of bradykinin's effects occur at a local tissue level, influencing BP via release of nitric oxide and prostaglandins [60] . Through interaction with bradykinin B 1 and B 2 receptors bradykinin promotes diuresis and natriuresis. Bradykinin B 1 receptors are expressed by differentiating renal tubules [62] and mediate potentially proinflammatory effects. Mice lacking B 1 receptors are normotensive and protected from inflammation and acute kidney injury (AKI) [63] . B 2 receptor knockout mice demonstrate saltsensitive hypertension and renal dysgenesis.
Bradykinin in renal disease
While capable of proinflammatory activation, bradykinin antagonizes activation of the reninangiotensin system, opposing ATII induced vasoconstriction, hypoxia, and proinflammatory activation [61 & ,64]. Bradykinin synthesis is protective against hypertensive renal damage and diabetic nephropathy [65, 66] . Studies of the selective kinases ebelactone B and poststatin indicate promise as novel antihypertensive agents [67] . Bradykinin's actions are prolonged by the use of ACE inhibitors, with potentiation of renal bradykinin a potential advantageous therapeutic effect of the ACE inhibitors, in addition to a cause of angioedema [68] . Both kinin receptor inhibition and kinin B 1 and B 2 receptor knockout mice are protected against cisplatininduced AKI [69
& ], with B 1 receptor antagonists also reducing fibrosis after experimental UUO, presumably because of inhibition of bradykinin's proinflammatory actions including promotion of migration of immune cells to injured tissue [71] .
PROSTAGLANDINS
Three pathways of arachidonic acid metabolism exist, mediated by cyclooxygenase (COX), lipoxygenase and cytochrome P450 enzymes. Of these, we will focus on the COX-generated compounds which are believed to be the most important for renal tubuletubule signaling [2] although other arachidonic acid metabolites (e.g., epoxyeicosatrienoic acids or 20-hydroxyeicosatetraenoic acid derived from the P450 system) can alter epithelial sodium transport, glomerular hemodynamics, and vascular reactivity and have anti-inflammatory effects [72,73 & ]. Inducible COX2 generates prostaglandin I 2 and is expressed within the cortical thick ascending limb of the loop of Henle, while the cells of the medullary TAL and collecting duct express constitutive COX1 [74] . Both COX1 and COX2 enzymes produce prostanoids in the normal and diseased kidney. The metabolites of COX1 and COX2 have important roles within the kidney, regulating blood flow, affecting the release of renin, and mediating NaCl excretion [74] . Although these functions fulfill important physiologic roles, increased levels of COX metabolites are seen in disease states and likely contribute to inflammatory injury.
Prostaglandins in renal disease
COX2-derived prostanoids are renal vasodilators [75 && ] and the inhibition of this effect by nonsteroidal anti-inflammatory drugs likely contributes to their nephrotoxicity [76] . Levels of COX2 increase in response to renal insults, aging, diabetes [77] , heart failure [78] , and lithium treatment [79] ; in some cases COX2 inhibition has been reported to be protective [80] . Within the kidneys of diabetics, COX2's vasodilatory effects may be maladaptive with human studies demonstrating COX2 inhibition reversing hyperfiltration [81] . In isolated glomeruli fluid flow sheer stress resulted in increased albumin permeability, which was reversed by indomethacin, a COX inhibitor [82] .
CYTOKINE PRODUCTION BY SENESCENT OR GAP 2/MITOSIS-ARRESTED TUBULAR CELLS
Our group has demonstrated that models of severe and progressive renal injury (UUO, AAN, and severe IRI) show accumulation of tubular cells in the Gap 2/mitosis (G2/M) phase of the cell cycle [83] . These cells adopt a profibrotic profile in vivo and in vitro, secreting growth factors, including connective tissue growth factor and TGF-b1, in addition to increased collagen 4a1 and 1a1 mRNA [83] (Fig. 3) . Thus, cell cycle arrest can induce paracrine signaling from tubular cells themselves which can be a key component of the fibrotic response to renal injury, a hypothesis supported by recent reports from other laboratories [84] [85] [86] . Pharmacological inhibition of G2/M-arrested cells reduced fibrosis, whereas increases in the G2/M-arrested proportion of cells in the cell cycle exacerbated fibrosis [84] [85] [86] .
Paracrine signaling is a recognized feature of senescent tubular cells expressing p16INK4a [87] .
These cells accumulate with aging and renal injury, producing TGF-b, epidermal growth factor (EGF), insulin like growth factor (IGF)-1, and vascular endothelial growth factor (VEGF), promoting fibrogenesis and further senescence with impaired tubular proliferation. Studies in progeroid mice demonstrate that depletion of senescent cells delays aging and increases healthy lifespan [88] .
Transgenic mice expressing the simian diphtheria toxin receptor allow the study of the effects of selective, repeated tubular injury on kidney signaling, function and scarring. Repeated tubular injury results in tubular, vascular and glomerular loss with increased fibrosis [89] . The response of tubular cells to acute injury, including expression of TGF-b acting as a paracrine and autocrine signal, has been implicated as important in determining fibrotic outcomes and eventual glomerulosclerosis [90, 91] 
Tubuloglomerular feedback
Communication between tubules and the glomerulus is vital to maintain homeostasis. We have previously referred to indirect tubular-glomerular feedback via peritubular capillary rarefaction and vasoconstriction [89] . In addition, there are well studied mechanisms of tubuloglomerular feedback (TGF) involving the macula densa (Fig. 4) . The juxtaglomerular apparatus is made up of renin-producing juxtaglomerular cells in the afferent arteriole and the adjacent salt-sensing macula densa cells of the TAL of the distal nephron derived from the same glomerulus [92] . Altered NaCl concentration in the tubular lumen of the distal nephron results in altered glomerular arteriolar resistance [73 & ] Reduced tubular NaCl delivery results in increases in single nephron glomerular filtration rate, and vice versa [73 & ,93] . There are also reports of contacts between the TAL and the efferent arteriole, and between tubular cells adjacent to the macula densa and the afferent arteriole, signaling via ATP release [92] .
Changes in the distal nephron luminal fluid tonicity result in altered glomerular hemodynamics via intracellular Ca 2þ signaling. Classic studies demonstrate that Ca 2þ flux is essential for TGF responses to alter NaCl delivery [94, 95] . Briefly, TGF is initiated when NaCl enters the macula densa cells via the two isoforms of the sodium potassium chloride co-transporter 2 (NKCC2) channel [96] . Recent use of multiphoton microscopy in vivo is facilitating new studies and insights into the cells and processes involved [97 && ]. Current understanding of TGF implicates adenosine, acting via the adenosine A1 receptor as a critical vasoconstrictor of the afferent arteriole, with carbon monoxide, nitric oxide, and kinin compounds as net vasodilatory modulators, and, with AT2, superoxide, 20-hydroxyeicosatetraenoic acid, and thromboxane all contributing to vasoconstriction [73 & ].
Tubuloglomerular feedback in renal disease
Although TGF balances to balance NaCl excretion via alterations in glomerular filtration rate under Tubular crosstalk Ferenbach and Bonventre normal physiological conditions, in subtotal nephrectomy models of chronic nephron loss a partial reversal of the system has been observed, with increased tubular NaCl at the macula densa causing increases in single nephron GFR [73 & ,98], mediated in part by overactivity of NOS [99] . Inappropriate modulation of the TGF system in diabetes contributes to the development of hyperfiltration [100] . Sodium glucose cotransporter 2 inhibition in these patients reduced clinical hyperfiltration via effects on macula densa cells and with inhibited pathogenic TGF [101] . Recent work shows reduced total and cardiovascular mortality in diabetics taking sodium glucose cotransporter 2 inhibitors [102 && ], potentially linking regulation of tubular signaling to patient survival.
CONCLUSION
Several pathways facilitate communication among adjacent, proximate, and distant renal tubular cells, vasculature, interstitial cells and glomeruli. This complex communication system is highly adaptive under normal physiological states but with pathology can turn maladaptive. Better understanding of these interactions in disease and the effects of agents, such as angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, and non steroidal anti-inflammatory drugs, and other drugs, on these complex paracrine and autocrine signaling pathways should provide interventional strategies to counter maladaptive signals and responses. Given the substantial impact of hypertension, diabetes, and CKD on global health, understanding maladaptive communication pathways and acquiring tools to intervene and protect tubular cells, and prevent interstitial fibrosis, remains a pressing clinical need.
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